ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 081,57
-0,26%
Dow Jones
39 094,38
0,07%
DAX
18 620,46
-0,35%
Brent Oil
81,685
0,46%
Bitcoin
67 189,73
-1,08%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Astrazeneca Plc (AZN)

  7. Astrazeneca Plc (AZN) Actualités

AZN

Astrazeneca (AZN)

Astrazeneca Plc
De:
Trier par:
 Showing the most relevant articles for your search:LSE:AZN
DateHeureSourceTitreSymboleSociété
21/05/202413h18Alliance NewsAlliance NewsEXTRA: AstraZeneca pins hopes on pipeline as plans new era of growthLSE:AZNAstrazeneca Plc
21/05/202409h18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aimLSE:AZNAstrazeneca Plc
21/05/202408h00RNS Regulatory NewsAstraZeneca PLC AstraZeneca to deliver $80bn revenue by 2030LSE:AZNAstrazeneca Plc
20/05/202409h24Alliance NewsAlliance NewsTOP NEWS: AstraZeneca plans to build manufacturing plant in SingaporeLSE:AZNAstrazeneca Plc
20/05/202408h00RNS Regulatory NewsAstraZeneca PLC AstraZeneca to manufacture ADCs in SingaporeLSE:AZNAstrazeneca Plc
16/05/202411h27Alliance NewsAlliance NewsAstraZeneca trials yield positive results for immunocompromised patientsLSE:AZNAstrazeneca Plc
16/05/202408h00RNS Regulatory NewsAstraZeneca PLC SUPERNOVA Trial Met COVID-19 prevention endpointLSE:AZNAstrazeneca Plc
15/05/202416h00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
08/05/202410h44Alliance NewsAlliance NewsAstraZeneca says withdraws Covid vaccine "for commercial reasons"LSE:AZNAstrazeneca Plc
07/05/202408h00RNS Regulatory NewsAstraZeneca PLC AstraZeneca completes Cellectis equity investmentLSE:AZNAstrazeneca Plc
06/05/202408h46Alliance NewsAlliance NewsAstraZeneca completes collaboration and investment deal with CellectisLSE:AZNAstrazeneca Plc
02/05/202411h04Alliance NewsAlliance NewsAstraZeneca notes positive trial results for Calquence treatmentLSE:AZNAstrazeneca Plc
02/05/202408h00RNS Regulatory NewsAstraZeneca PLC Calquence combination improved PFS in 1L MCLLSE:AZNAstrazeneca Plc
01/05/202416h00RNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
29/04/202410h13Alliance NewsAlliance NewsAstraZeneca makes progress with Truqap and Enhertu cancer treatmentsLSE:AZNAstrazeneca Plc
29/04/202408h05RNS Regulatory NewsAstraZeneca PLC Truqap recommended for EU breast cancer approvalLSE:AZNAstrazeneca Plc
29/04/202408h00RNS Regulatory NewsAstraZeneca PLC Enhertu improved PFS in HER2-low and ultralowLSE:AZNAstrazeneca Plc
25/04/202414h00PR Newswire (US)AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingLSE:AZNAstrazeneca Plc
25/04/202410h18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growthLSE:AZNAstrazeneca Plc
25/04/202408h00RNS Regulatory NewsAstraZeneca PLC 1st Quarter ResultsLSE:AZNAstrazeneca Plc
24/04/202411h32Alliance NewsAlliance NewsAngle shares jump on supplier agreement with with AstraZenecaLSE:AZNAstrazeneca Plc
16/04/202412h38Alliance NewsAlliance NewsIN THE KNOW: Deutsche ups AstraZeneca as higher payout addresses worryLSE:AZNAstrazeneca Plc
16/04/202409h39Alliance NewsAlliance NewsAstraZeneca's hails Imfinzi survival data on cancer formLSE:AZNAstrazeneca Plc
11/04/202418h42Alliance NewsAlliance News*AstraZeneca AGM resolutions pass, but 36% vote against remuneration policyLSE:AZNAstrazeneca Plc
11/04/202418h30RNS Regulatory NewsAstraZeneca PLC Result of AGMLSE:AZNAstrazeneca Plc
11/04/202409h56Alliance NewsAlliance NewsTOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023LSE:AZNAstrazeneca Plc
11/04/202408h00RNS Regulatory NewsAstraZeneca PLC AstraZeneca increases 2024 dividend by 7%LSE:AZNAstrazeneca Plc
08/04/202409h36Alliance NewsAlliance NewsTOP NEWS: AstraZeneca hails neurological data for Ultomiris, SolirisLSE:AZNAstrazeneca Plc
08/04/202408h00RNS Regulatory NewsAstraZeneca PLC Enhertu approved in US for HER2+ solid tumoursLSE:AZNAstrazeneca Plc
08/04/202407h53Alliance NewsAlliance NewsTOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approvalLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN

Dernières Valeurs Consultées

BOV
NINJ3Q
Getninjas ON
EU
ALLEC
Cogelec
NASDAQ
VOD
Vodafone
NYSE
SM
SM Energy
BOV
GRMA6L
Gramacosa PNB
EU
ALCLA
Clasquin
EU
RFBX
Reseau Ferre de France R...
EU
H907T
H907T
EU
HAL
Hal
EU
4754T
4754T
NYSE
BLK
BlackRock
EU
H295S
H295S
BOV
SBFG3R
Grupo SBF ON
EU
F920T
F920T
EU
F437S
F437S
EU
MLAEM
Ashler Et Manson
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés